Articles from February 2013
Posted by Site Administrator on February 28, 2013
Mark your calendars!
Join us for 2 fun and worthwhile events coming your way to help in the fight to end ALS!
#
RASCALS 4th Annual Trivia Night – September 7, 2013
#
Fight ALS One Step At A Time 5K Run/Walk – November 2, 2013
#
All proceeds help ALS Research and Family Assistance
Join us in making a difference this year!
Stay [...]
Categories: 501(c)(3) Non-Profit, RASCALS Foundation News
| 
Tags: 501(c)(3) ALS charity, ALS, ALS 5K Run/Walk, ALS community, ALS family assistance, ALS research, ALS research funding, ALS treatments, ALS trivia night, amyotrophic lateral sclerosis, Bob Stehlin, Fight ALS One Step At A Time 5K Run/Walk, PALS, RASCALS 4th Annual Trivia Night ALS, RASCALS 5K Walk Certified Run, RASCALS Foundation, Robert A. Stehlin Campaign for ALS, St.Louis RASCALS ALS Lou Gehrig's Disease amotrophic lateral sclerosis
| 
No comments
Posted by Site Administrator on February 28, 2013
The RASCALS Foundation is pleased to announce that it is once again offering the 2013 Higher Education Scholarship Program to assist families affected by ALS. We would like to acknowledge and thank our corporate partner, Walgreens, for their generous participation in making these important awards possible.
The scholarships will be available nationwide to the first 100 [...]
Categories: 501(c)(3) Non-Profit, Caretakers, RASCALS Foundation News
| Tags: 2013 ALS Scholarships, ALS, ALS community, ALS donations, ALS education scholarship, ALS family assistance, ALS family education assistance, ALS Scholarships, amyotrophic lateral sclerosis, Bob Stehlin, PALS, RASCALS 2013 Higher Education Scholarship Program, RASCALS Foundation, RASCALS scholarships ALS, Robert A. Stehlin Campaign for ALS, St.Louis RASCALS ALS Lou Gehrig's Disease amotrophic lateral sclerosis, Walgreens
| No comments
Posted by Site Administrator on February 28, 2013
Strong’s team is convinced ALS is a disorder of RNA metabolism. RNA is the intermediary or messenger between genes and the protein being made. This new protein appears to play a critical role. “Every time we look at a cell degenerating, this particular protein was deposited abnormally in the cell. It was a common denominator,” explains Strong, who is also the Dean of Schulich Medicine & Dentistry. “Working with Dr. Rob Hegele at Robarts, we found there was a genetic mutation in the gene coding for this protein. So it’s a huge discovery.”
Categories: Research News, Treatments
| Tags: ALS, ALS community, ALS cure, ALS medical care, ALS research, ALS research funding, ALS treatments, amyotrophic lateral sclerosis, Amyotrophic Lateral Sclerosis and Frontotemporal Degeneration, ARHGEF28 gene ALS, Bob Stehlin, Canada ALS, Dr. Michael Strong ALS, Dr. Rob Hegele, Lou Gehrig's disease, PALS, RASCALS Foundation, RNA metabolism ALS, Robarts Research Institute, Robert A. Stehlin Campaign for ALS, Schulich School of Medicine & Dentistry, St.Louis RASCALS ALS Lou Gehrig's Disease amotrophic lateral sclerosis, Western University in London, World Federation of Neurology Research Group on Motor Neuron Disease
| No comments
Posted by Site Administrator on February 12, 2013
Globs of protein clustered in the neurons that control muscles have long been the hallmark of amyotrophic lateral sclerosis (ALS), the fatal neurodegenerative disease also commonly known as Lou Gehrig’s disease. Now, a study of the most commonly found mutant gene in people with ALS reveals an unexpected origin of some of those sticky masses, a finding that may offer drug developers a new target for treatments.
Categories: Research News, Treatments
| Tags: ALS, ALS community, ALS research, ALS research funding, ALS treatments, ALS-FTD, amyotrophic lateral sclerosis, Barrow Neurological Institute in Phoenix, Bob Stehlin, Bryan Traynor, C9ORF72 gene, C9orf72 mutations, Dieter Edbauer, dipeptide repeat (DPR) proteins, GGGGCC-laden C9orf72, Lou Gehrig's disease, Ludwig Maximilians University Munich in Germany, National Institute on Aging in Bethesda Maryland, neurodegenerative process ALS, PALS, protein clusters ALS, RASCALS Foundation, Robert A. Stehlin Campaign for ALS, St.Louis RASCALS ALS Lou Gehrig's Disease amotrophic lateral sclerosis, TDP-43, University of Antwerp in Belgium
| No comments
Posted by Site Administrator on February 12, 2013
“This new finding sheds light on how the mutation causes these disorders, and it provides us with a marker that helps us track disease progression in patients with this disorder and potentially combat the disease,” says senior author Leonard Petrucelli, Ph.D., a molecular neuroscientist and director of the Department of Neuroscience at Mayo Clinic in Florida.
Categories: Research News, Technology, Treatments
| Tags: ALS community, ALS medical care, ALS research, ALS research funding, ALS treatments, amyotrophic lateral sclerosis, biomarker ALS, Bob Stehlin, C9ORF72 gene, C9RANT, Department of Neuroscience at Mayo Clinic Florida, DNA sequence ALS, frontotemporal dementia, Leonard Petrucelli, Lou Gehrig's disease, Mayo Clinic, motor neuron cells, Motor Neuron Disease, National Institutes of Health, neurodegenerative disorders, neuronal death and toxicity, PALS, RASCALS Foundation, Robert A. Stehlin Campaign for ALS, St.Louis RASCALS ALS Lou Gehrig's Disease amotrophic lateral sclerosis
| No comments
